CH EPL (R5)
0.1.0 - ci-build

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: 66231001

Generated Narrative: RegulatedAuthorization MA-66231001

identifier: http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MarketingAuthorisationNumber/66231001

subject: PackagedProductDefinition: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-PCID#CH-7601001001138-6623101-001; containedItemQuantity = 1 Vial; description = KEYTRUDA Inf Konz 100 mg/4ml Durchstf

type: Marketing Authorisation

region: Switzerland

status: zugelassen

statusDate: 2022-02-17

holder: Organization MSD Merck Sharp & Dohme AG

regulator: Organization SMC

Generated Narrative: Organization #holder-MSD-Merck-Sharp-Dohme-AG

identifier: urn:oid:1.2.276.0.76/100080484, GLN/7601001001138

name: MSD Merck Sharp & Dohme AG

Generated Narrative: Organization #regulator-SMC

identifier: urn:oid:1.2.276.0.76/100010911, GLN/7601001398511

name: SMC